Back to News
Market Impact: 0.15
Medicinal Genomics Launches Next-Day Pathogen Testing for Dietary Supplements
Source: Business Wire
Product LaunchesHealthcare & BiotechTechnology & Innovation
Medicinal Genomics launched next-day qPCR pathogen testing for dietary supplements, which it says was independently validated as equivalent to USP <2022> plating. The announcement provides no pricing, sales, or adoption figures.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
More News
- South Korean carmaker Hyundai plans 'strategic' investment of $15.5 billion in India by 2032
- Applied Materials’ $5 billion AI lab aims to cut chip development time in half—and restore Silicon Valley’s edge
- Meta’s Muse models reach the AI frontier—and kill any hopes to ‘pace’ it
- Mainspring, AEP Strike Deal to Bring Power Online Faster
- Why this little known Chinese chipmaker has caused a global stock rout
- Applied Materials CEO on Doubling Revenue Thanks To AI